- Bayer AG
- Bayer HealthCare AG
- Pfizer Inc.
- Bristol-Myers Squibb Co.
- AstraZeneca PLC
- GlaxoSmithKline PLC
- ViiV Healthcare
- Flexion Therapeutics Inc.
- Eli Lilly & Co.
- Covance Inc.
- Ionis Pharmaceuticals Inc.
- Exelixis Inc.
- Johnson & Johnson
- Ortho-McNeil Inc.
- Eisai Co. Ltd.
- Alexza Pharmaceuticals Inc.
- Inspiration Biopharmaceuticals Inc.
- Quintiles Transnational Holdings Inc.
- Novartis AG
- Pfizer acquires Wyeth in $67bn deal
- Lilly sells manufacturing site to Covance, signs R&D contract
- Isis, Ortho-McNeil sign metabolic drug development deal
- Symphony Neuro licenses Guilford's GPI 1485
- Exelixis gets additional funding for GSK deal
- Alexza forms financing vehicle to support CNS agents
- Dynavax gets $50mm in special funding from Symphony
- Ipsen, Inspiration sign hemophilia deal; renegotiated; terminated
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.